Date | Time | Source | Headline | Symbol | Company |
05/15/2024 | 2:30PM | iHub Newswire | FeaturedIntegrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share | | |
04/03/2024 | 7:30AM | GlobeNewswire Inc. | Reunion Neuroscience Inc. Announces Upcoming Presentations at the Anxiety and Depression Association of America (ADAA) 2024 Conference | NASDAQ:REUN | Reunion Neuroscience Inc |
03/27/2023 | 7:30AM | GlobeNewswire Inc. | Reunion Neuroscience Abstract Accepted for Poster Presentation at 2023 ASCP Annual Meeting | NASDAQ:REUN | Reunion Neuroscience Inc |
03/13/2023 | 6:52PM | GlobeNewswire Inc. | Reunion Neuroscience Files Lawsuit Against Mindset Pharma | NASDAQ:REUN | Reunion Neuroscience Inc |
03/07/2023 | 7:30AM | GlobeNewswire Inc. | Reunion Neuroscience to Participate in the Oppenheimer Annual Healthcare Conference | NASDAQ:REUN | Reunion Neuroscience Inc |
02/14/2023 | 7:30AM | GlobeNewswire Inc. | Reunion Neuroscience Provides Business Update and Reports Fiscal Third Quarter 2023 Financial Results | NASDAQ:REUN | Reunion Neuroscience Inc |
02/02/2023 | 7:30AM | GlobeNewswire Inc. | Reunion Neuroscience Schedules Fiscal Third Quarter 2023 Conference Call for Tuesday, February 14, 2023, at 8:30 A.M. ET | NASDAQ:REUN | Reunion Neuroscience Inc |
01/18/2023 | 7:30AM | GlobeNewswire Inc. | Reunion Neuroscience Appoints Robert Alexander as Chief Medical Officer | NASDAQ:REUN | Reunion Neuroscience Inc |
01/09/2023 | 7:30AM | GlobeNewswire Inc. | Reunion Neuroscience Inc. Completes Interim Data Analysis for Phase 1 Clinical Trial with Novel Serotonergic Psychedelic RE104 | NASDAQ:REUN | Reunion Neuroscience Inc |
01/04/2023 | 7:30AM | GlobeNewswire Inc. | Reunion Neuroscience Inc. Provides 2023 Corporate Update | NASDAQ:REUN | Reunion Neuroscience Inc |
12/16/2022 | 8:35AM | GlobeNewswire Inc. | KCSA Mental Health Virtual Investor Conference: Presentations Now Available for Online Viewing | NASDAQ:REUN | Reunion Neuroscience Inc |
12/13/2022 | 8:35AM | GlobeNewswire Inc. | KCSA Mental Health Virtual Investor Conference Agenda Announced for December 15th | NASDAQ:REUN | Reunion Neuroscience Inc |
12/06/2022 | 8:00AM | GlobeNewswire Inc. | Reunion Neuroscience Inc. to Participate in Upcoming Investor Conferences in December | NASDAQ:REUN | Reunion Neuroscience Inc |
11/18/2022 | 5:05PM | GlobeNewswire Inc. | Reunion Neuroscience Puts in Place At-The-Market Equity Facility | NASDAQ:REUN | Reunion Neuroscience Inc |
11/16/2022 | 6:20AM | TipRanks | Analysts Offer Insights on Healthcare Companies: BELLUS Health (BLU), Reunion Neuroscience (REUN) and Mainz Biomed B.V. (MYNZ) | NASDAQ:REUN | Reunion Neuroscience Inc |
11/14/2022 | 7:30AM | GlobeNewswire Inc. | Reunion Neuroscience Inc. Provides Business Update and Reports Fiscal Second Quarter 2023 Financial Results | NASDAQ:REUN | Reunion Neuroscience Inc |
11/07/2022 | 7:30AM | GlobeNewswire Inc. | Reunion Neuroscience Schedules Fiscal Second Quarter 2023 Conference Call for Monday, November 14, 2022, at 8:30 A.M. ET | NASDAQ:REUN | Reunion Neuroscience Inc |
10/31/2022 | 7:30AM | GlobeNewswire Inc. | Reunion Neuroscience to Present at Upcoming November Conferences | NASDAQ:REUN | Reunion Neuroscience Inc |
10/24/2022 | 7:30AM | GlobeNewswire Inc. | Reunion Neuroscience Appoints Chief Financial Officer and Vice President, Medical Affairs | NASDAQ:REUN | Reunion Neuroscience Inc |
10/12/2022 | 7:30AM | GlobeNewswire Inc. | Reunion Neuroscience CEO to Participate on Panel at 2022 Horizons Perspectives on Psychedelics Conference | NASDAQ:REUN | Reunion Neuroscience Inc |
10/07/2022 | 5:34PM | TipRanks | Reunion Neuroscience general counsel Paula Amy Hewitt resigns | NASDAQ:REUN | Reunion Neuroscience Inc |
10/07/2022 | 5:30PM | GlobeNewswire Inc. | Reunion Neuroscience Inc. Announces Executive Changes | NASDAQ:REUN | Reunion Neuroscience Inc |
10/03/2022 | 7:30AM | GlobeNewswire Inc. | Reunion Neuroscience to Participate in the Cantor Neurology & Psychiatry Conference | NASDAQ:REUN | Reunion Neuroscience Inc |
09/29/2022 | 5:20PM | GlobeNewswire Inc. | Reunion Neuroscience Inc. Announces Results of Annual General and Special Shareholder Meeting | NASDAQ:REUN | Reunion Neuroscience Inc |
09/28/2022 | 7:30AM | GlobeNewswire Inc. | Reunion Neuroscience Inc. Appoints Greg Mayes as President and Chief Executive Officer | NASDAQ:REUN | Reunion Neuroscience Inc |
09/08/2022 | 8:00AM | GlobeNewswire Inc. | Reunion Neuroscience Inc. to Participate in Upcoming Investor Conferences | NASDAQ:REUN | Reunion Neuroscience Inc |
08/31/2022 | 7:30AM | GlobeNewswire Inc. | Reunion Neuroscience Inc. Announces 2022 Annual General Meeting of Shareholders | NASDAQ:REUN | Reunion Neuroscience Inc |